AstraZeneca Oncology R&D Head On China Biotech Innovation

Looking Again At New Deals

 
• By Dexter Jie Yan
China drug R&D
China's biotech innovation has attracted AstraZeneca back to deal-making in the country • Source: Shutterstock

More from China

More from Focus On Asia